OXiGENE, Inc. of Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementOxigene Inc • July 21st, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledJuly 21st, 2010 Industry JurisdictionOXiGENE, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC, a Delaware limited liability company (“MLV”), as follows: